Clinical Trials Directory

Trials / Completed

CompletedNCT01193543

Effect of Calanus Oli on Intra-abdominal Fat, Glucose Tolerance and Lipids in Man

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
117 (actual)
Sponsor
University of Tromso · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

Preliminary studies in rats and mice indicate that calanus oil reduce accumulation of intra-abdominal fat. Pilot studies in humans have shown no adverse effects. In the present study 120 subjects, males and females, 20-65 years old, BMI 25-30 kg/m2 will be included and given calanus oli 1 g twice daily versus placebo for 1 year. The hypothesis is that calanus oil will reduce intra-abdominal fat, improve glucose tolerance and lipid profile.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTcalanus oil1 gram twice daily
DIETARY_SUPPLEMENTolive oil1 gram twice daily

Timeline

Start date
2010-12-01
Primary completion
2012-06-01
Completion
2012-08-01
First posted
2010-09-02
Last updated
2012-09-05

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT01193543. Inclusion in this directory is not an endorsement.